PuSH - Publication Server of Helmholtz Zentrum München

Jakob, M.* ; Mattes, L.* ; Küffer, S.* ; Unger, K. ; Hess J. ; Bertlich, M.* ; Haubner, F.* ; Ihler, F.* ; Canis, M.* ; Weiss, B.* ; Kitz, J.*

MicroRNA expression patterns in oral squamous cell carcinoma: Hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.

Head Neck 41, 3499-3515 (2019)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
BACKGROUND: MicroRNAs (miRNA) recently evolved as potential cancer biomarkers. Therefore, the aim of the present study was to evaluate the prognostic impact of eight miRNAs connected to oral squamous cell carcinoma (OSCC). METHOD: Expression levels of hsa-mir-21-5p, hsa-mir-29b-3p, hsa-mir-31-5p, hsa-mir-99a-5p, hsa-mir-99b-3p, hsa-mir-100-5p, hsa-mir-143-3p and hsa-mir-155-5p were analyzed in tumor tissue (n = 36) and healthy oral mucosal tissue (n = 17) and correlated with clinical variables. Results of the study cohort were validated in an OSCC cohort of The Cancer Genome Atlas. RESULTS: Increased hsa-mir-99b-3p expression level showed a tendency toward advanced tumor stages, and high levels of hsa-mir-100-5p expression were associated with extracapsular extension. While a high expression level of hsa-mir-99b-3p was associated with better survival, a high expression level of hsa-mir-100-5p was correlated with a poorer survival in the study cohort. CONCLUSION: Our results indicate that hsa-mir-99b-3p and hsa-mir-100-5p may serve as novel prognostic biomarkers in OSCC.
Altmetric
Additional Metrics?
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Biomarker ; Hsa-mir-100-5p ; Hsa-mir-99b-3p ; Microrna ; Oral Squamous Cell Carcinoma ; Prognosis
ISSN (print) / ISBN 1043-3074
e-ISSN 1097-0347
Journal Head and Neck
Quellenangaben Volume: 41, Issue: 10, Pages: 3499-3515 Article Number: , Supplement: ,
Publisher Wiley
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Research Unit Radiation Cytogenetics (ZYTO)
CCG Personalized Radiotherapy in Head and Neck Cancer (KKG-KRT)